Clinical Trial Update: A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity [Phase 2, Phase 3]

View source ↗

Summary

This entry notes the completion of Phase 2/Phase 3 trials evaluating the effectiveness and safety of topiramate for moderate to severe binge-eating disorder ass…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder
• Obesity

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Obesity, Binge-Eating Disorder | Phase 2, Phase 3 | Status: COMPLETED